UBS Investment Bank has hired four senior investment bankers into its healthcare banking group. Denis Fabre, Steven Fisch, Les Franks and Holly Sheffield will join the firm’s Investment Banking Department (IBD) as managing directors.
Reportedly, Mr. Fisch, Mr. Franks and Ms. Sheffield will report to Robert DiGia, global head of healthcare banking, and will be based in New York City. Mr. Fabre will be based in London and report to Doug McCutcheon, head of healthcare for Europe, Middle East and Africa (EMEA) and Asia-Pacific (APAC).
Mr. Fabre will be responsible for the medical technology and services segments of healthcare in EMEA. He was most recently a managing director on the healthcare team at Deutsche Bank.
Mr. Fisch will have responsibility for life sciences coverage efforts. He most recently worked as an independent consultant advising healthcare companies. Mr. Franks will oversee sectors within services including distribution, pharmaceutical services and healthcare information technology. He will join UBS from Thomas Weisel Partners where he was a managing director on their healthcare team.
Ms. Sheffield will be responsible for banking coverage for all subsectors of medical technology. She will join UBS after 13 years at Credit Suisse where she was most recently a managing director in healthcare banking in San Francisco and New York.
Mr. DiGia said: “Mr. Denis, Mr. Steven, Mr. Les and Ms. Holly are each outstanding in their fields, with proven credibility advising top-tier clients and delivering strategic solutions. We are thrilled they will be joining UBS and are confident they will continue to strengthen and advance our coverage of the sector, offering unique, strategic advisory and financing solutions for clients.”
Rick Leaman, global head of IBD, said: “Healthcare is an important and key sector to UBS. By bringing on board talented and highly sought after bankers like Mr. Denis, Mr. Steven, Mr. Les and Ms. Holly, it demonstrates UBS’s commitment to growing this integral part of the business. I believe we will quickly see an impact from their addition to the healthcare banking group.”
